ADMS

Adamas Pharmaceuticals
ADMS

Delisted

ADMS was delisted on the 23rd of November, 2021.

97 hedge funds and large institutions have $207M invested in Adamas Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 41 increasing their positions, 26 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.47M
Puts
$462K
Net Calls
Net Calls Change

Top Buyers

1 +$11M
2 +$7.88M
3 +$5.62M
4
Morgan Stanley
Morgan Stanley
New York
+$4.32M
5
AllianceBernstein
AllianceBernstein
Tennessee
+$3.24M

Top Sellers

1 -$18.2M
2 -$12.3M
3 -$10.2M
4
PA
Perceptive Advisors
New York
-$8.45M
5
SI
Sofinnova Investments
California
-$6.92M
Name Holding Trade Value Shares
Change
Change in
Stake
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125